1
|
ElMansy MM, Tadros SST, Saleh RS, Abdelmonem R, El Menoufy H, Shawky N. Comparative evaluation on the effect of different cavity disinfectant nano gels; Chlorohexidine, Propolis, Liquorice versus Diode Laser in terms of composite microleakage (comparative in vitro study). BDJ Open 2023; 9:49. [PMID: 37951940 PMCID: PMC10640611 DOI: 10.1038/s41405-023-00176-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2023] [Revised: 09/26/2023] [Accepted: 10/06/2023] [Indexed: 11/14/2023] Open
Abstract
INTRODUCTION The application of different cavity disinfectants is an essential step that eliminates bacteria after cavity preparation. However, some of these materials may affect restoration sealing ability. AIM This study aimed to assess the degree of microleakage at the tooth restoration interface after using different nano prepared cavity disinfectants versus Diode Laser. MATERIALS AND METHODS Three disinfectants were prepared on the nanoscale; Propolis, Liquorice and Chlorhexidine. A total of 40 extracted premolars with standard class V cavities were prepared on the facial surface. Teeth were divided into five groups according to the applied cavity disinfection protocol; no treatment, Chloehexidine, Propolis, Liquorice, and Diode Laser. After application of composite resin restoration, all teeth were subjected to thermocycling, afterwords the degree of microleakage was measured in micrometers. Data were analyzed by one-way analysis of variance (ANOVA) test, followed by Bonferroni's and Tukey's post hoc test. RESULTS The highest mean microlekage value was recorded in no treatment group, followed by Liquorice, Propolis. While Diode Laser group showed the lowest degree of microleakage. CONCLUSION Diode Laser cavity disinfectant has no negative effect on the restoration sealing ability. Nano prepared Propolis showed comparative results to nanoChloehexidine as both had low degree of microleakage.
Collapse
Grants
- Maryam Mohamed ElMansy 1 Researcher of Pediatric Dentistry, Orthodontic and Pediatric Dentistry Department, Orodental Institute, National Research Centre, Dokki, Giza, Egypt. Silvia Sabry Tawfik Tadros 2 Lecturer of Conservative Dentistry, Conservative Surgery Department, College of Oral and Dental Surgery, Misr University for Science and Technology(MUST), 6th of October City, Giza, Egypt
Collapse
Affiliation(s)
- Maryam Mohamed ElMansy
- Researcher of Pediatric Dentistry, Orthodontic and Pediatric Dentistry Department, Orodental Institute, National Research Centre, Dokki, Giza, Egypt
| | - Silvia Sabry Tawfik Tadros
- Lecturer of Conservative Dentistry, Conservative Surgery Department, College of Oral and Dental Surgery, Misr University for Science and Technology(MUST), 6th of October City, Giza, Egypt
| | - Reham Sayed Saleh
- Researcher of Restorative Dentistry, Restorative and Dental Materials Department, Orodental Institute, National Research Centre, Dokki, Giza, Egypt.
| | - Rehab Abdelmonem
- Professor of Industrial Pharmacy, Department of Industrial Pharmacy, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology (MUST), 6th of October City, Giza, Egypt
| | - Hala El Menoufy
- Dean of Faculty of Dentistry, Professor of Laser Research Centre, Misr University for Science and Technology(MUST), 6th of October City, Giza, Egypt
| | - Naglaa Shawky
- Professor of Oral Medicine, Department of Oral Medicine, Periodontology, Diagnosis and Radiology, Al Azhar University, Laser Research Centre, Misr University for Science and Technology(MUST), 6th of October City, Giza, Egypt
| |
Collapse
|
2
|
Ghosh A, Ghosh B, Parihar N, Ilaweibaphyrnai M, Panda SR, Alexander A, Chella N, Murty U, Naidu V, Kumar G J, Pemmaraju DB. Nutraceutical prospects of Houttuynia cordata against the infectious viruses. FOOD BIOSCI 2022; 50:101977. [PMID: 36059903 PMCID: PMC9423882 DOI: 10.1016/j.fbio.2022.101977] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2021] [Revised: 08/04/2022] [Accepted: 08/11/2022] [Indexed: 11/17/2022]
Abstract
The novel enveloped β-coronavirus SARS-CoV-2 (COVID-19) has offered a surprising health challenge all over the world. It develops severe pneumonia leading to acute respiratory distress syndrome (ARDS). Like SARS-COV-2, other encapsulated viruses like HIV, HSV, and influenza have also offered a similar challenge in the past. In this regard, many antiviral drugs are being explored with varying degrees of success to combat the associated pathological conditions. Therefore, upon scientific validation & development, these antiviral phytochemicals can attain a futuristic nutraceutical prospect in managing different encapsulated viruses. Houttuynia cordata (HC) is widely reported for activities such as antioxidant, anti-inflammatory, and antiviral properties. The major antiviral bioactive components of HC include essential oils (methyl n-nonyl ketone, lauryl aldehyde, capryl aldehyde), flavonoids (quercetin, rutin, hyperin, quercitrin, isoquercitrin), and alkaloids (norcepharadione B) & polysaccharides. HC can further be explored as a potential nutraceutical agent in the therapy of encapsulated viruses like HIV, HSV, and influenza. The review listed various conventional and green technologies that are being employed to extract potent phytochemicals with diverse activities from the HC. It was indicated that HC also inhibited molecular targets like 3C-like protease (3CLPRO) and RNA-dependent RNA polymerase (RdRp) of COVID-19 by blocking viral RNA synthesis and replication. Antioxidant and hepatoprotective effects of HC have been evident in impeding complications from marketed drugs during antiviral therapies. The use of HC as a nutraceutical is localized within some parts of Southeast Asia. Further technological advances can establish it as a nutraceutical-based functional food against pathogenic enveloped viruses like COVID 19.
Collapse
Affiliation(s)
- Aparajita Ghosh
- Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Assam, 781101, India
| | - Bijoyani Ghosh
- Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Assam, 781101, India
| | - Nidhi Parihar
- Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Assam, 781101, India
| | - Myrthong Ilaweibaphyrnai
- Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Assam, 781101, India
| | - Samir R Panda
- Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Assam, 781101, India
| | - Amit Alexander
- Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research Guwahati, Assam, 781101, India
| | - Naveen Chella
- Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research Guwahati, Assam, 781101, India
| | - Usn Murty
- Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Assam, 781101, India
| | - Vgm Naidu
- Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Assam, 781101, India
| | - Jagadeesh Kumar G
- Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Assam, 781101, India
| | - Deepak B Pemmaraju
- Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Assam, 781101, India
| |
Collapse
|
3
|
Garcia MT, Ward RADC, Gonçalves NMF, Pedroso LLC, Neto JVDS, Strixino JF, Junqueira JC. Susceptibility of Dental Caries Microcosm Biofilms to Photodynamic Therapy Mediated by Fotoenticine. Pharmaceutics 2021; 13:pharmaceutics13111907. [PMID: 34834321 PMCID: PMC8619263 DOI: 10.3390/pharmaceutics13111907] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2021] [Revised: 11/03/2021] [Accepted: 11/05/2021] [Indexed: 01/20/2023] Open
Abstract
Photodynamic therapy (PDT) mediated by Fotoenticine® (FTC), a new photosensitizer derived from chlorin e-6, has shown in vitro inhibitory activity against the cariogenic bacterium Streptococcus mutans. However, its antimicrobial effects must be investigated on biofilm models that represent the microbial complexity of caries. Thus, we evaluated the efficacy of FTC-mediated PDT on microcosm biofilms of dental caries. Decayed dentin samples were collected from different patients to form in vitro biofilms. Biofilms were treated with FTC associated with LED irradiation and analyzed by counting the colony forming units (log10 CFU) in selective and non-selective culture media. Furthermore, the biofilm structure and acid production by microorganisms were analyzed using microscopic and spectrophotometric analysis, respectively. The biofilms from different patients showed variations in microbial composition, being formed by streptococci, lactobacilli and yeasts. Altogether, PDT decreased up to 3.7 log10 CFU of total microorganisms, 2.8 log10 CFU of streptococci, 3.2 log10 CFU of lactobacilli and 3.2 log10 CFU of yeasts, and reached eradication of mutans streptococci. PDT was also capable of disaggregating the biofilms and reducing acid concentration in 1.1 to 1.9 mmol lactate/L. It was concluded that FTC was effective in PDT against the heterogeneous biofilms of dental caries.
Collapse
Affiliation(s)
- Maíra Terra Garcia
- Department of Biosciences and Oral Diagnosis, Institute of Science and Technology/ICT, São Paulo State University/UNESP, São José dos Campos 12245-000, Brazil; (M.T.G.); (R.A.d.C.W.); (N.M.F.G.); (L.L.C.P.)
| | - Rafael Araújo da Costa Ward
- Department of Biosciences and Oral Diagnosis, Institute of Science and Technology/ICT, São Paulo State University/UNESP, São José dos Campos 12245-000, Brazil; (M.T.G.); (R.A.d.C.W.); (N.M.F.G.); (L.L.C.P.)
| | - Nathália Maria Ferreira Gonçalves
- Department of Biosciences and Oral Diagnosis, Institute of Science and Technology/ICT, São Paulo State University/UNESP, São José dos Campos 12245-000, Brazil; (M.T.G.); (R.A.d.C.W.); (N.M.F.G.); (L.L.C.P.)
| | - Lara Luise Castro Pedroso
- Department of Biosciences and Oral Diagnosis, Institute of Science and Technology/ICT, São Paulo State University/UNESP, São José dos Campos 12245-000, Brazil; (M.T.G.); (R.A.d.C.W.); (N.M.F.G.); (L.L.C.P.)
| | - José Vieira da Silva Neto
- Associate Laboratory of Sensors and Materials/LABAS, National Institute for Space Research, São José dos Campos 12227-010, Brazil;
| | - Juliana Ferreira Strixino
- Photobiology Applied to Health, Research and Development Institute IP&D, University of Vale do Paraiba/UNIVAP, São José dos Campos 12244-390, Brazil;
| | - Juliana Campos Junqueira
- Department of Biosciences and Oral Diagnosis, Institute of Science and Technology/ICT, São Paulo State University/UNESP, São José dos Campos 12245-000, Brazil; (M.T.G.); (R.A.d.C.W.); (N.M.F.G.); (L.L.C.P.)
- Correspondence:
| |
Collapse
|
4
|
Gomaa AA, Abdel-Wadood YA. The potential of glycyrrhizin and licorice extract in combating COVID-19 and associated conditions. PHYTOMEDICINE PLUS : INTERNATIONAL JOURNAL OF PHYTOTHERAPY AND PHYTOPHARMACOLOGY 2021; 1:100043. [PMID: 35399823 PMCID: PMC7886629 DOI: 10.1016/j.phyplu.2021.100043] [Citation(s) in RCA: 57] [Impact Index Per Article: 14.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/08/2021] [Revised: 02/02/2021] [Accepted: 02/05/2021] [Indexed: 04/28/2023]
Abstract
BACKGROUND Several recent studies have stated that glycyrrhizin and licorice extract are present in most traditional Chinese medicine formulas used against SARS-CoV-2 in China. Significant data are showing that glycyrrhizin and licorice extract have multiple beneficial activities in combating most features of SARS-CoV-2. PURPOSE The aim of current review was to highlight recent progresses in research that showed the evidence of the potential use of glycyrrhizin and licorice extract against COVID-19. METHODOLOGY We have reviewed the information published from 1979 to October 2020. These studies demonstrated the effects , use and safety of glycyrrhizin and icorice extract against viral infections,bacterial infections, inflammatory disorders of lung ( in vitro and in vivo). These studies were collated through online electronic databases research (Academic libraries as PubMed, Scopus, Web of Science and Egyptian Knowledge Bank). RESULTS Pooled effect size of articles provides information about the rationale for using glycyrrhizin and licorice extract to treat COVID-19. Fifty studies demonstrate antiviral activity of glycyrrhizin and licorice extract. The most frequent mechanism of the antiviral activity is due to disrupting viral uptake into the host cells and disrupting the interaction between receptor- binding domain (RBD) of SARS-COV2 and ACE2 in recent articles. Fifty studies indicate that glycyrrhizin and licorice extract have significant antioxidant, anti-inflammatory and immunomodulatory effects. Twenty five studies provide evidence for the protective effect of glycyrrhizin and licorice extract against inflammation-induced acute lung injury and cardiovascular disorders. CONCLUSION The current study showed several evidence regarding the beneficial effects of glycyrrhizin and licorice extract in combating COVID-19. More randomized clinical trials are needed to obtain a precise conclusion.
Collapse
Key Words
- 18β-GA, 18β-glycyrrhetinic acid
- : ACE2, angiotensin-converting enzyme 2
- ALI, acute lung injury
- ARDS, acute Respiratory Distress Syndrome
- Acute lung injury protector
- COVID-19
- COVID-19, Coronavirus disease 2019
- COX-2, cyclooxygenase-2
- DCs, dendritic cells
- Gl, glycyrrhizin
- Glycyrrhizin and licorice extract;Antiviral and antimicrobial, Anti-inflammatory and antioxidant
- HBsAg, hepatitis B surface antigen
- HCV, hepatitis C virus
- HMGB1, high-mobility group box 1
- IL, interleukin
- Immunododulator
- MAPKs, mitogen-activated protein kinases
- MERS, Middle East respiratory syndrome
- MR, mineralocorticoid receptor
- MRSA, Methicillin-resistant Staphylococcus aureus
- NO, nitric oxide
- RBD, receptor-binding domain
- ROS, reactive oxygen species
- S, Spike
- SARS, severe acute respiratory syndrome
- TCM, traditional Chinese medicine
- TLR, toll-like receptor
- TMPRSS2, type 2 transmembrane serine protease
- TNF-α, tumor necrosis factor alpha
- h, hour
- iNOS, inducible nitric oxide synthase
- licorice extract, LE
Collapse
Affiliation(s)
- Adel A Gomaa
- Department of Medical Pharmacology, Faculty of Medicine, Assiut Universitya, Beni-Suif, Egypt
| | | |
Collapse
|